Korean J Gastroenterol.  2021 Jul;78(1):37-47. 10.4166/kjg.2021.053.

Subjective Needs and Thoughts for the Treatment of Patients with Inflammatory Bowel Disease: Applying Q Methodology

• Park YE
• Lee J
• Park J
• Choi JH
• Heo NY
• Park SH
• Lee YK
• Kim TO

• KMID: 2518749
• DOI: http://doi.org/10.4166/kjg.2021.053

Abstract

Background/Aims
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a chronic inflammatory disorder of the gastrointestinal tract that requires lifetime management. Many studies have attempted to establish questionnaires and/or parameters to assess the quality of care for IBD patients. However, no study to date has investigated patients using the Q-methodology, which is subjective and has been studied systematically, to identify and categorize their opinions and subjective thinking about their disease and treatment. We have therefore aimed here to conduct a preliminary study of the Q-methodology to investigate the subjective thinking of IBD patients in Korea.
Methods
Q-methodology, a method of analyzing the subjectivity of questionnaire items, was examined in this study. Inputs from 50 IBD patients were classified into 34 normalized statements using a 9-point scale with a normal distribution. The collected data were analyzed using the QUANL PC program.
Results
Using the Q-methodology, IBD patients were classified into type I, II, III, and IV treatment needs: medical staff-dependent, relationship-oriented, information-driven, and social awareness, respectively.
Conclusions
The subjective needs of IBD patients and their thoughts about the treatment can be classified into four types. Our findings suggest that we can establish a systematic strategy for personalized care according to patient type.

Keyword

Inflammatory bowel diseases; Q methodology; Quality of health care

Figure

• 

  Fig. 1 Q methodology.

• 

  Fig. 2 Q- grid.

Reference

1. Ye BD, Travis S. 2019; Improving the quality of care for inflammatory bowel disease. Intest Res. 17:45–53. DOI: 10.5217/ir.2018.00113. PMID: 30449081. PMCID: PMC6361018.

2. Egberg MD, Gulati AS, Gellad ZF, Melmed GY, Kappelman MD. 2018; Improving quality in the care of patients with inflammatory bowel diseases. Inflamm Bowel Dis. 24:1660–1669. DOI: 10.1093/ibd/izy030. PMID: 29718299. PMCID: PMC6231366.

3. Kwak MS, Cha JM, Lee HH, et al. 2019; Emerging trends of inflammatory bowel disease in South Korea: a nationwide population-based study. J Gastroenterol Hepatol. 34:1018–1026. DOI: 10.1111/jgh.14542. PMID: 30447025.

4. Kappelman MD, Palmer L, Boyle BM, Rubin DT. 2010; Quality of care in inflammatory bowel disease: a review and discussion. Inflamm Bowel Dis. 16:125–133. DOI: 10.1002/ibd.21028. PMID: 19572335.

5. Burisch J, Jess T, Martinato M, Lakatos PL. ECCO -EpiCom. 2013; The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 7:322–337. DOI: 10.1016/j.crohns.2013.01.010. PMID: 23395397.

6. Berry SK, Siegel CA, Melmed GY. 2017; Quality improvement initiatives in inflammatory bowel disease. Curr Gastroenterol Rep. 19:41. DOI: 10.1007/s11894-017-0581-x. PMID: 28730508.

7. Berry SK, Melmed GY. 2018; Quality indicators in inflammatory bowel disease. Intest Res. 16:43–47. DOI: 10.5217/ir.2018.16.1.43. PMID: 29422796. PMCID: PMC5797270.

8. Melmed GY, Siegel CA, Spiegel BM, et al. 2013; Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 19:662–668. DOI: 10.1097/mib.0b013e31828278a2. PMID: 23388547.

9. Calvet X, Panés J, Alfaro N, et al. 2014; Delphi consensus statement: quality indicators for inflammatory bowel disease comprehensive care units. J Crohns Colitis. 8:240–251. DOI: 10.1016/j.crohns.2013.10.010. PMID: 24295646.

10. Nguyen GC, Devlin SM, Afif W, et al. 2014; Defining quality indicators for best-practice management of inflammatory bowel disease in Canada. Can J Gastroenterol Hepatol. 28:275–285. DOI: 10.1155/2014/941245. PMID: 24839622. PMCID: PMC4049258.

11. Donabedian A. 1988; The quality of care. How can it be assessed? JAMA. 260:1743–1748. DOI: 10.1001/jama.1988.03410120089033.

12. Soares JB, Nogueira MC, Fernandes D, Gonçalves BM, Gonçalves R. 2015; Validation of the Portuguese version of a questionnaire to measure quality of care through the eyes of patients with inflammatory bowel disease (QUOTE-IBD). Eur J Gastroenterol Hepatol. 27:1409–1417. DOI: 10.1097/MEG.0000000000000485. PMID: 26441206.

13. Pittet V, Vaucher C, Froehlich F, Maillard MH, Michetti P. Swiss IBD Cohort Study Group. 2018; Patient-reported healthcare expectations in inflammatory bowel diseases. PLoS One. 13:e0197351. DOI: 10.1371/journal.pone.0197351. PMID: 29772017. PMCID: PMC5957384.

14. Peyrin-Biroulet L, Sandborn W, Sands BE, et al. 2015; Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 110:1324–1338. DOI: 10.1038/ajg.2015.233. PMID: 26303131.

15. Bossuyt P, Vermeire S. 2016; Treat to target in inflammatory bowel disease. Curr Treat Options Gastroenterol. 14:61–72. DOI: 10.1007/s11938-016-0077-z. PMID: 26864745.

16. Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. 2014; IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol. 11:88–98. DOI: 10.1038/nrgastro.2013.240. PMID: 24345891.

17. Burisch J, Kiudelis G, Kupcinskas L, et al. 2019; Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. Gut. 68:423–433. DOI: 10.1136/gutjnl-2017-315568. PMID: 29363534.

18. Gallagher K, Porock D. 2010; The use of interviews in Q methodology: card content analysis. Nurs Res. 59:295–300. DOI: 10.1097/NNR.0b013e3181e4ffff. PMID: 20585225.

19. Paige JB, Morin KH. 2016; Q-sample construction: a critical step for a Q-methodological study. West J Nurs Res. 38:96–110. DOI: 10.1177/0193945914545177. PMID: 25092207.

20. Kim HK. 2008. Q methodology: philosophy, theories, analysis, and application. Communication Books;Seoul: p. 78–191.

21. Choi CH, Jung SA, Lee BI, et al. 2009; Diagnostic guideline of ulcerative colitis. Korean J Gastroenterol. 53:145–160.

22. Brown SR. 1993; A primer on Q methodology. Operant Subjectivity. 16:91–138.

23. Ah CJ, Han KB. 2014; Recognition on suicidal intent of the elderly among caregivers: a Q-methodological application. Korean Journal of Adult Nursing. 26:522–532. DOI: 10.7475/kjan.2014.26.5.522.

24. Park KS. 2009; A study on the subjective perception patterns of social workers to corporate philanthropy in social work field. Korean Jounal of Social Welfare. 61:109–136. DOI: 10.20970/kasw.2009.61.4.005.

25. Ye BD, Jang BI, Jeen YT, et al. 2009; Diagnostic guideline of Crohn's disease. Korean J Gastroenterol. 53:161–176.

26. Brown SR. 1980. Political subjectivity: applications of Q methodology in political science. Yale University Press;London:

27. van der Eijk I, Sixma H, Smeets T, et al. 2001; Quality of health care in inflammatory bowel disease: development of a reliable questionnaire (QUOTE-IBD) and first results. Am J Gastroenterol. 96:3329–3336. DOI: 10.1016/S0002-9270(01)03896-5.